Search for: "R L S Interests Inc" Results 161 - 180 of 2,158
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Sep 2021, 5:27 am by Vercammen Law
DeMarco, Esq.DeMarco & DeMarco, Esqs.Counsel for Defendants, Anthony Russo, Jr., Washington Avenue Group, LLC, and the Estate of Anthony Russo, Sr.Beth L. [read post]
3 Sep 2021, 2:05 pm by Bill Marler
Cir. 1981) (“an agency must receive and respond to petitions for rulemaking”); Nat’l Parks Conserv. [read post]
26 Aug 2021, 2:59 pm by Kevin LaCroix
I welcome guest post submissions from responsible authors on topics of interest to this blog’s readers. [read post]
23 Aug 2021, 1:39 pm by Christiana Wayne
Development Resources, inc. [read post]
22 Aug 2021, 4:00 am by SOQUIJ
Ainsi, un établissement d’enseignement privé pourrait s’exposer, en cas de contravention à l’article 16 de la loi, aux sanctions énumérées à l’article 272, dont la seule recherchée en l’espèce est la réduction de l’obligation. [read post]
20 Aug 2021, 10:21 am by Rebecca Tushnet
D’artagnan, Inc., 2021 WL 1138017, No. 19-CV-6158 (MKB) (E.D.N.Y. [read post]
18 Aug 2021, 4:00 am by Administrator
À l’instar de la Cour suprême dans l’affaire Teskey, l’appel peut être résolu en évaluant s’il y a crainte légitime de partialité en raison d’une justification a posteriori qui vienne compromettre la présomption d’intégrité du juge dans les circonstances particulières de l’affaire. [read post]
28 Jul 2021, 9:43 am by Administrator
The post Wednesday: What’s Hot on CanLII appeared first on Slaw. [read post]
18 Jul 2021, 4:00 am by Administrator
L’instance de révision a confirmé cette décision. [read post]
15 Jul 2021, 2:54 pm by Kevin LaCroix
I welcome guest post submissions from responsible authors on topics of interest to this blog’s readers. [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]